Everything below concerns Gly-His-Lys. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-01. Numbers and descriptions here follow the published literature rather than marketing material.
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.
Published work on GHK-Cu is dominated by in vitro experiments and small animal studies. Human trials tend to be short and small, with endpoints such as skin appearance rather than clinical outcomes. Review articles often summarize the same underlying laboratory findings, which can make the evidence base look broader than it is. Several basic questions remain open: the concentration of the intact complex in human tissue, the route by which it crosses the skin barrier, and whether effects seen in culture produce measurable changes in people.
Laboratory studies describe GHK-Cu as a source of copper that cells can take up, with reported effects on collagen, elastin, and glycosaminoglycan synthesis in cultured fibroblasts. The peptide also appears in wound-repair research, where it is linked to the activity of matrix metalloproteinases and their inhibitors. These observations come largely from cell and animal models. How directly the complex controls any single pathway in intact human skin remains an open question, and reported effects depend on concentration, vehicle, and exposure time.
| Property | Value | Notes |
|---|---|---|
| INCI name | Copper tripeptide-1 | Standard designation on cosmetic ingredient labels |
| Peptide sequence | Gly-His-Lys | Three-residue ligand; binding occurs at the histidine side chain |
| Metal-to-peptide ratio | 1 to 1 | One copper(II) ion per peptide unit |
| Appearance | Blue to violet powder | Colour arises from copper-to-peptide electronic transitions |
| Water solubility | Freely soluble | Commonly formulated in aqueous or water-alcohol systems |
Dry material is typically held at low temperature, often around minus twenty degrees Celsius, and protected from moisture and light. Copper complexes can release their metal ion under acidic conditions or in the presence of competing chelators. Hydrolysis of the peptide backbone is a slower but real pathway, and the histidine residue is susceptible to oxidation over long periods. Stability statements therefore depend on formulation, pH, and container, and they should be read as conditional rather than absolute.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Copper content is measured separately by techniques such as inductively coupled plasma mass spectrometry or atomic absorption. Amino acid analysis confirms the peptide sequence after hydrolysis. Because the metal and the peptide can be quantified independently, a complete certificate of analysis normally reports both values rather than a single purity figure. This separation of measurements is important when comparing suppliers.
Solid GHK-Cu appears as a blue to blue-violet powder, and the colour is a direct consequence of copper coordination. The complex dissolves readily in water and in many polar solvents, while the free peptide behaves differently. Solubility in nonpolar media is low, which limits its use in oil-based systems. Solutions are typically prepared fresh because the dissolved form is more exposed to hydrolysis and to loss of the metal ion than the dry powder. Working concentrations are usually low, and preparation notes often specify the solvent and the order of addition.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry to confirm the expected mass. Copper content is measured separately by inductively coupled plasma optical emission spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not establish the metal-to-peptide ratio. Visible spectroscopy provides a rapid check on complex integrity through the absorption band in the visible region. Agreement between the peptide assay and the copper assay is the practical test of whether a sample is the intended complex rather than a mixture.
Aqueous solutions of GHK-Cu are less stable than the dry powder. The peptide backbone is vulnerable to hydrolysis at extreme pH, and copper can be stripped from the complex by strong chelating agents such as EDTA or citrate. Oxidising agents and high concentrations of ascorbic acid can reduce copper(II) and change the complex, which is one reason formulators often keep such ingredients in separate phases. How quickly these changes occur under real storage conditions depends on pH, buffer, temperature and packaging, and quantitative data on the subject are limited.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
The compound entered scientific literature in the 1970s, when plasma factors with copper-binding activity were isolated and characterized. Later work expanded into wound healing, skin biology, and cosmetic formulation, where copper tripeptide-1 became a recognized ingredient name. Most published studies remain preclinical or small-scale, and findings are often reported in specialized dermatology or peptide journals. Regulatory treatment varies: some jurisdictions allow it as a cosmetic ingredient, while research-grade material is sold for laboratory use. Questions about optimal delivery, target tissues, and long-term effects continue to be investigated rather than settled.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide sequence is often abbreviated Gly-His-Lys, and the copper is bound through the histidine imidazole nitrogen and adjacent peptide nitrogens. The complex is frequently described as a 1:1 peptide-to-copper species. It occurs naturally in human plasma, saliva, and urine at low concentrations. Its endogenous levels have been reported to decline with age, although the precise physiological role of that change remains an open question.
Research interest in GHK-Cu centers on its ability to deliver copper and to influence cellular processes in laboratory models. In cell culture and animal studies, the complex has been linked to collagen synthesis, antioxidant enzyme activity, and expression of genes associated with tissue remodeling. These effects are not equivalent to proven clinical outcomes. The mechanisms proposed include copper transfer to cuproenzymes, modulation of growth factor signaling, and interactions with extracellular matrix components. How much of the observed activity depends on intact GHK-Cu versus free copper or free peptide is not fully resolved.
The main method of treatment for potential death from signaling-related diseases involves either increasing or decreasing the susceptibility of apoptosis in diseased cells, depending on whether the disease is caused by either the inhibition of or excess apoptosis. For instance, treatments aim to restore apoptosis to treat diseases with deficient cell death and to increase the apoptotic threshold to treat diseases involved with excessive cell death. To stimulate apoptosis, one can increase the number of death receptor ligands (such as TNF or TRAIL), antagonize the anti-apoptotic Bcl-2 pathway, or introduce Smac mimetics to inhibit the inhibitor (IAPs). The addition of agents such as Herceptin, Iressa, or Gleevec works to stop cells from cycling and causes apoptosis activation by blocking growth and survival signaling further upstream. Finally, adding p53-MDM2 complexes displaces p53 and activates the p53 pathway, leading to cell cycle arrest and apoptosis. Many different methods can be used either to stimulate or to inhibit apoptosis in various places along the death signaling pathway. Apoptosis is a multi-step, multi-pathway cell-death programme that is inherent in every cell of the body. In cancer, the apoptosis cell-division ratio is altered. Cancer treatment by chemotherapy and irradiation kills target cells primarily by inducing apoptosis.
== Career == Dandridge began her career appearing in Chicago theatre productions. She has gained a wider audience as the voice of Alyx Vance in the award-winning action game Half-Life 2 and its sequels, Episode One and Episode Two, and also as Marlene in The Last of Us. In 2006, she was cast as Kala in the original Broadway production of Tarzan. Dandridge earned a BAFTA Award for her voiceover performance in the 2015 game Everybody's Gone to the Rapture. On television, she guest starred on NCIS, 24, Criminal Minds, The Newsroom and Drop Dead Diva. In 2022, she was cast in a series regular role as Chief in the ABC drama series Station 19. Dandridge also had the recurring roles in the FX drama series, Sons of Anarchy as Rita Roosevelt, and short-lived The CW teen soap Star-Crossed in 2014. In 2015, she co-starred in the second season of NBC medical drama, The Night Shift as Gwen Gaskin. In 2015, Dandridge was cast as the lead character in the Oprah Winfrey Network drama series, Greenleaf opposite Lynn Whitfield. She plays the role of Grace Greenleaf, Greenleaf's estranged daughter. Dandridge has received critical acclaim for her first leading screen role. From November 9, 2017, to January 7, 2018, Dandridge starred as Papa Ge the God of Death in the Broadway musical revival of Once on This Island, at the Circle in the Square Theater. She returned to the role of Papa Ge in a limited run from June 18 to August 19, 2018. Along with cast, she received Grammy Award for Best Musical Theater Album nomination for cast recording.
== Physical properties == The boiling points of the pentane isomers range from about 9 to 36 °C. As is the case for other alkanes, the more thickly branched isomers tend to have lower boiling points. The same tends to be true for the melting points of alkane isomers, and that of isopentane is 30 °C lower than that of n-pentane. However, the melting point of neopentane, the most heavily branched of the three, is 100 °C higher than that of isopentane. The anomalously high melting point of neopentane has been attributed to the tetrahedral molecules packing more closely in solid form; this explanation is contradicted by the fact that neopentane has a lower density than the other two isomers, and the high melting point is actually caused by neopentane's significantly lower entropy of fusion. The branched isomers are more stable (have lower heat of formation and heat of combustion) than n-pentane. The difference is 1.8 kcal/mol for isopentane, and 5 kcal/mol for neopentane. Rotation about two central single C-C bonds of n-pentane produces four different conformations.
(2026) recover ancient DNA from mammoth ivory from the Hohle Fels cave (Germany), and report evidence of presence of mammoth specimens from multiple distinct lineages in the studied sample. Zanina et al. (2026) reconstruct the environment and diet of the woolly mammoth calf specimen "Yana" from the Batagay section (Sakha, Russia) on the basis of the study of contents of its gastrointestinal tract and the material found between its forelimbs. A new, nearly complete skeleton of a woolly mammoth, identified as a male aged approximately 30–40 years, is described from the latest Pleistocene strata from the Taymyr Peninsula (Russia) by Petrova et al. (2026). Moots et al. (2026) determine sex of 521 woolly mammoth specimens on the basis of the study of ancient DNA, reporting evidence indicating that mammoths from bone accumulation sites were predominantly female, while mammoths from other depositional settings were predominantly male, and interpret these findings as suggestive of anthropogenic origin of mammoth bone accumulations and of preferential targeting of mammoth females by humans. Hannold et al. (2026) reconstruct the diets of pygmy mammoths from Northern Channel Islands and Columbian mammoths from Rancho La Brea and coastal Santa Barbara in southern California on the basis of stable isotopes in tooth enamel. Evidence from the study of tooth enamel of Columbian mammoths from 14 sites in the Central Basin of Mexico, interpreted as indicative of a generalist diet with varying proportions of C3 and C4 plants, is presented by Rodríguez-Franco et al. (2026).
== Absorption == Azinphos-methyl can enter the body via inhalation, ingestion and dermal contact. Ingestion of azinphos-methyl is responsible for the low-dose exposure to a large part of the population, due to their presence as residues in food and drinking water. After ingestion it can be absorbed from the digestive tract. By skin contact, AzM can also enter the body through dermal cells. Absorption through the skin is responsible for the occupational exposure to relatively high doses, mainly in agriculture workers.
Sources: en.wikipedia.org
== Background on native platelets == Native platelets play a vital role in hemostasis, the process of blood clotting and wound healing. Also known as thrombocytes, platelets are anucleate cell fragments derived from megakaryocytes in the bone marrow. Under healthy conditions, platelets circulate in an inactive state within the bloodstream and rapidly respond to vascular injury by initiating a complex cascade of coagulation events to prevent excessive blood loss. Native platelets are 2-3 micrometers in diameter and possess a highly specialized structure that enables their function in clot formation. Their cytoplasm contains dense granules and alpha granules, which store essential molecules such as adenosine diphosphate (ADP), serotonin, fibrinogen, and growth factors. These molecules are important for platelet activation, adhesion, and recruitment of additional platelets during vascular injury. The platelet membrane contains an abundance of glycoproteins, including integrins and receptors like glycoprotein Ib-IX-V and glycoprotein IIb/IIIa, which mediate interactions with the vascular endothelium and other platelets. A cytoskeleton composed of actin and tubulin allows platelets to change shape during activation, which extends filopodia to enhance adhesion and clot stability. Platelets engage in the following three-step process to form a stable blood clot: adhesion, activation, and aggregation.
It is not known how mature RALF peptide is produced from its precursor, but a dibasic amino acid motif (typical of recognition sites of processing enzymes in yeast and animals) is located two residues upstream from the amino terminus of mature RALF. RALF has been identified to bind to potential membrane bound receptors complex containing proteins 25 kDa and 120 kDa in size. SCR/SP11 — are small polymorphic peptides produced by the tapetal cells of anthers and is involved in self-incompatibility of Brassica species. This secreted polypeptide is between 78 and 80 amino acid residues in length. Unlike other peptide hormones, no further post-translational processing occurs, except for the removal of the N-terminal signal peptide. SCR/SP11 like other small peptide hormones binds to a membrane bound LRR receptor like kinase (SRK). ROTUNDIFOLIA4/DEVIL1 (ROT4/DVL1) — The ROT4 and DVL1 are peptides of 53 and 51 amino acids respectively, which have a high degree of sequence homology. They are two members of 23 member peptide family. ROT4 and DVL1 are involved in regulating polar cell proliferation on the longitudinal axis of organs. Inflorescence deficient in abscission (IDA) — a family of secreted peptides identified to be involved in petal abscission. The peptides are 77 amino acids in length and possess an amino-terminal secretions signal. Like the CLE peptide family these proteins have a conserved carboxy-terminal domain that is bordered by potentially cleavable basic residues. These proteins are secreted from cells in the floral abscission zone.
Arguing in favour of independence, President Mangope claimed that the move would enable its population to negotiate with Pretoria from a stronger position: "We would rather face the difficulties of administering a fragmented territory, the wrath of the outside world, and accusations of ill-informed people. It's the price we are prepared to pay for being masters of our own destiny." United Nations Secretary-General Kurt Waldheim stated that he "strongly deplored" the establishment of "another so-called independent tribal homeland in pursuance of the discredited policies of apartheid", and in resolution A/RES/32/105N, passed on 14 December 1977, the United Nations General Assembly linked Bophuthatswana's "so-called 'independence'" to South Africa's "stubborn pursuit" of its policies, and called upon all governments to "deny any form of recognition to the so-called 'independent' bantustans". During a parliamentary debate in the UK on 6 December 1977, Foreign Secretary David Owen replied in the negative when asked "whether Her Majesty's Government intend to recognise travel documents issued by the authorities of ... Bophuthatswana for the purpose of admitting visitors to the United Kingdom". While the majority of news reports echoed these official declarations, there were others which opined that Western critics should "suspend judgment for a time", and despite its generally critical stance on South Africa's policies, Time magazine wrote that Bophuthatswana had "considerable economic potential" with an expected $30 million a year coming from mining revenues.
The four substrates of this enzyme are (−)-(S)-limonene, reduced nicotinamide adenine dinucleotide phosphate (NADPH), oxygen, and a proton. Its products are (−)-perillyl alcohol, oxidised NADP+, and water. This enzyme is a cytochrome P450 protein containing heme. This oxidoreductase, which uses molecular oxygen as oxidant is in a group with systematic name (S)-limonene,NADPH:oxygen oxidoreductase (7-hydroxylating). Other names in common use include (−)-limonene 7-monooxygenase, (−)-limonene hydroxylase, (−)-limonene monooxygenase, and (−)-limonene,NADPH:oxygen oxidoreductase (7-hydroxylating). In Perilla frutescens it is part of the biosynthetic pathway to perillaldehyde.
Sources: en.wikipedia.org
However, a sufficiently chemically skilled malicious actor could extract a volatile species from inert material and/or achieve a similar effect of dispersion by physically grinding the inert matrix into a fine dust.
==== Usage in global industry ==== Direct oxidation of ethylene was patented by Lefort in 1931. This method was repeatedly modified for industrial use, and at least four major variations are known. They all use oxidation by oxygen or air and a silver-based catalyst, but differ in the technological details and hardware implementations. Union Carbide (currently a division of Dow Chemical Company) was the first company to develop the direct oxidation process. A similar production method was developed by Scientific Design Co., but it received wider use because of the licensing system – it accounts for 25% of the world's production and for 75% of world's licensed production of ethylene oxide. A proprietary variation of this method is used by Japan Catalytic Chemical Co., which adapted synthesis of both ethylene oxide and ethylene glycol in a single industrial complex. A different modification was developed Shell International Chemicals BV. Their method is rather flexible with regard to the specific requirements of specific industries; it is characterized by high selectivity with respect to the ethylene oxide product and long lifetime of the catalyst (3 years). It accounts for about 40% of global production. Older factories typically use air for oxidation whereas newer plants and processes, such as METEOR and Japan Catalytic, favor oxygen.
=== Bodyplans === Swimming animals including fish such as herrings, marine mammals such as dolphins, and ichthyosaurs (of the Mesozoic) all converged on the same streamlined shape. A similar shape and swimming adaptations are even present in molluscs, such as Phylliroe. The fusiform bodyshape (a tube tapered at both ends) adopted by many aquatic animals is an adaptation to enable them to travel at high speed in a high drag environment. Similar body shapes are found in the earless seals and the eared seals: they still have four legs, but these are strongly modified for swimming. The marsupial fauna of Australia and the placental mammals of the Old World have several strikingly similar forms, developed in two clades, isolated from each other. The body, and especially the skull shape, of the thylacine (Tasmanian tiger or Tasmanian wolf) converged with those of Canidae such as the red fox, Vulpes vulpes.
Although mild hypokalemia does not cause distinct symptoms, it is a risk factor for hypertension and cardiac arrhythmia. Severe hypokalemia usually presents with hypertension, arrhythmia, muscle cramps, fatigue, weakness and constipation. Causes of hypokalemia include vomiting, diarrhea, medications like furosemide and steroids, kidney dialysis, diabetes insipidus, hyperaldosteronism, and hypomagnesemia.
=== Protein modification === A classic way to crystalize is by adding a small amount of protease to the droplet, as digestion may yield a more crystallizable fragment by removing unstructured regions. Chemical modification can be used to improve crystallization. The most commonly used is reductive methylation, which changes surface lysines in a way that usually reduces entropy.
Sources: en.wikipedia.org
It is a complex of a three-amino-acid peptide, glycine, histidine and lysine, bound to a single copper(II) ion. The metal is held mainly by the histidine side chain and the peptide backbone. Most commercial material is supplied as an acetate salt rather than as the free complex.
The free peptide was reported in 1973 by Loren Pickart, who isolated it from human plasma. Its copper-binding behaviour was characterised over the following years. The metal-bound form has been the subject of most later research.
Yes. Copper tripeptide-1 is the name used in cosmetic ingredient labelling, while GHK-Cu is the shorthand found in the scientific literature. Both refer to the same peptide-copper complex, and the two terms are interchangeable in most technical documents.
It is not approved as a pharmaceutical in major markets and is used mainly as a cosmetic ingredient and a laboratory reagent. Regulatory status varies by country and by the product category in which it appears. Claims about therapeutic effects should be treated separately from permitted cosmetic labeling.